Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Tango Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- −5 vs. Q1 2024
- Shares held
- 98.6M
- +278.7K (+0.3%) vs. Q1 2024
- Total value
- $846.0M
- +$65.4M (+8.4%) vs. Q1 2024
- New holders
- 20
- 39 more added
- Sold out
- 25
- 33 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bessemer Group Inc | 708,384 | $6.08M | 0.01% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 750,000 | $6.43M | 0.08% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 1,049,895 | $9.01M | 0.79% | −300,250−22.2% | Reduced |
| Casdin Capital, LLC | 1,188,349 | $10.2M | 0.78% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,225,552 | $10.5M | 0.00% | +92,017+8.1% | Added |
| Citadel Advisors LLC | 1,231,757 | $10.6M | 0.01% | +765,639+164.3% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,540,000 | $13.2M | 0.22% | 00.0% | Unchanged |
| State Street Corp | 1,828,259 | $15.7M | 0.00% | −1,037,839−36.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,294,206 | $19.7M | 0.04% | 00.0% | Unchanged |
| Artal Group S.A. | 2,519,841 | $21.6M | 0.56% | +325,000+14.8% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $24.8M | 2.72% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,294,572 | $28.3M | 0.00% | +213,687+6.9% | Added |
| BlackRock Inc. | 3,987,852 | $34.2M | 0.00% | +126,490+3.3% | Added |
| T. Rowe Price Investment Management, Inc. | 4,755,979 | $40.8M | 0.03% | +434,428+10.1% | Added |
| Southpoint Capital Advisors LP | 5,276,699 | $45.3M | 1.13% | 00.0% | Unchanged |
| Nextech Invest AG | 5,533,980 | $47.5M | 7.99% | 00.0% | Unchanged |
| Boxer Capital, LLC | 8,198,642 | $70.3M | 3.70% | 00.0% | Unchanged |
| FMR LLC | 9,409,078 | $80.7M | 0.01% | −82,577−0.9% | Reduced |
| EcoR1 Capital, LLC | 13,330,736 | $114.4M | 3.50% | 00.0% | Unchanged |
| TRV GP IV, LLC | 19,201,475 | $164.7M | 81.48% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −196,384−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −168,400−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −109,269−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −67,115−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −65,600−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −58,180−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −50,894−100.0% | Sold out |
| Integrity Wealth Solutions LLC | 0 | $0 | 0.00% | −33,199−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −30,429−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −24,405−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −22,001−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −21,494−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −21,338−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −15,900−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −15,779−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,172−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −12,296−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −11,467−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,897−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −10,398−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,484−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |